Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 3451 AL 3465

A Quantitative Analysis of Brain Soluble Tau and the Tau Secretion Factor

Han P, Serrano G, Beach TG, Caselli RJ, Yin J, Zhuang N, Shi J.

J Neuropathol Exp Neurol. 2017 Jan 1;76(1):44-51. doi: 10.1093/jnen/nlw105.

Alzheimer disease in 2016: Putting AD treatments and biomarkers to the test

Reiman EM.

Nat Rev Neurol. 2017 Feb;13(2):74-76. doi: 10.1038/nrneurol.2017.1. Epub 2017 Jan 13.

Selecting Aβ isoforms for an Alzheimer's disease cerebrospinal fluid biomarker panel

Somers C, Goossens J, Engelborghs S, Bjerke M.

Biomark Med. 2017 Feb;11(2):169-178. doi: 10.2217/bmm-2016-0276. Epub 2017 Jan 23.

Potential oxidative stress biomarkers of mild cognitive impairment due to Alzheimer disease

García-Blanco A, Baquero M, Vento M, Gil E, Bataller L, Cháfer-Pericás C.

J Neurol Sci. 2017 Feb 15;373:295-302. doi: 10.1016/j.jns.2017.01.020. Epub 2017 Jan 7.

Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the concept

Epelbaum S, Genthon R, Cavedo E, Habert MO, Lamari F, Gagliardi G, Lista S, Teichmann M, Bakardjian H, Hampel H, Dubois B.

Alzheimers Dement. 2017 Apr;13(4):454-467. doi: 10.1016/j.jalz.2016.12.003. Epub 2017 Feb 7.

Metabolomics in Alzheimer's disease: The need of complementary analytical platforms for the identification of biomarkers to unravel the underlying pathology

González-Domínguez R, Sayago A, Fernández-Recamales Á.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Dec 15;1071:75-92. doi: 10.1016/j.jchromb.2017.02.008. Epub 2017 Feb 6.

A second wind for the cholinergic system in Alzheimer's therapy

Douchamps V, Mathis C.

Behav Pharmacol. 2017 Apr;28(2 and 3-Spec Issue):112-123. doi: 10.1097/FBP.0000000000000300.

Dysregulation of lipids in Alzheimer's disease and their role as potential biomarkers

Wong MW, Braidy N, Poljak A, Pickford R, Thambisetty M, Sachdev PS.

Alzheimers Dement. 2017 Jul;13(7):810-827. doi: 10.1016/j.jalz.2017.01.008. Epub 2017 Feb 24.

Emerging biomarkers and screening for cognitive frailty

Ruan Q, D'Onofrio G, Sancarlo D, Greco A, Lozupone M, Seripa D, Panza F, Yu Z.

Aging Clin Exp Res. 2017 Dec;29(6):1075-1086. doi: 10.1007/s40520-017-0741-8. Epub 2017 Mar 4.

Recent Progress in Alzheimer's Disease Research, Part 3: Diagnosis and Treatment

Hane FT, Robinson M, Lee BY, Bai O, Leonenko Z, Albert MS.

J Alzheimers Dis. 2017;57(3):645-665. doi: 10.3233/JAD-160907.

T Lymphocytes and Inflammatory Mediators in the Interplay between Brain and Blood in Alzheimer's Disease: Potential Pools of New Biomarkers

Mietelska-Porowska A, Wojda U.

J Immunol Res. 2017;2017:4626540. doi: 10.1155/2017/4626540. Epub 2017 Feb 15.

Metabolomic-guided discovery of Alzheimer's disease biomarkers from body fluid

Enche Ady CNA, Lim SM, Teh LK, Salleh MZ, Chin AV, Tan MP, Poi PJH, Kamaruzzaman SB, Abdul Majeed AB, Ramasamy K.

J Neurosci Res. 2017 Oct;95(10):2005-2024. doi: 10.1002/jnr.24048. Epub 2017 Mar 16.

Alzheimer's disease biomarker development: a call to funding bodies

Frisoni GB, Jack CR Jr, Winblad B.

Neurobiol Aging. 2017 Apr;52:117-118. doi: 10.1016/j.neurobiolaging.2016.02.035.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias